Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Interventional
×
loncastuximab tesirine
×
Clear all
Filters
3
NCT04384484
2026-01-26
LOTIS 5
ADC Therapeutics S.A.
Phase 3
Active not recruiting
440 enrolled